HALO trade ideas
HALO Daily safe bet pharma swingVRTX I already own, looking to add some more pharma in due time.
HALO has good upside, I calculate +25 pct from 41.16 buy point to dashed line 51.63. 21/50/100 EMA crossover.
17.5 pct ROIC, 5.1 pct free cash flow yield (so so), accelerating revenue growth, buybacks, ROE 105%, Operating margin, 42.49 pct. Upward revised analyst projections.
The big negative, it has an obscene debt to equity ratio, and I do not like debt. Nevertheless, I would play this as a shorter term swing play to take advantage of pharma seasonality in December.
I would set an alert at the fib line at 41.16, which also is near the 100 day EMA (red line) and right on the top of the bullish cloud. If seasonality plays out correctly, we are looking at an entry in mid November. There could be an easy ride upward since the volume profile thins out above, and there is a 6 plus percent short ratio on the stock. It is showing what looks like a cup & handle (sort of), so it may not get below the bottom of the handle, so we will see what plays out.
Halozyme Therapeutics (HALO) - Frequency Formula Strategy - LongStrategy Overview: The Frequency Formula
Our trading strategy, "The Frequency Formula," is built on cutting-edge Fourier Wave Transform theory. The strategy utilizes four unique indicators: the Frequency Formula Chop Indicator (FF-CI), Frequency Formula Trend Indicator (FF-TI), the Frequency Formula Volume Indicator with Combined Ratios (FFVI-CR), and the Frequency Formula Net Buy/Net Sell Volume Indicator (FF-NBNS). Together, they identify optimal entry and exit points based on changes in market trends, volumes, and sentiments.
Why Now Is a Good Time to Enter
The FF-CI and FF-TI suggest that the current market chop and previous bearish trend are transitioning into a solid upward trend. Simultaneously, the FF-UVI-CR indicates increased buying volume and positive sentiment, suggesting strong support for the upward price movement.
What to Look for When Exiting
Keep an eye on our FF-VMI-CR and FF-NBNS Indicators. When the FF-VMI-CR indicator positive volume (blue) and negative volume (red) signals converge or "squeeze", this indicates a significant increase in net selling volume and might indicate a potential trend reversal; also, watch the FF-NBNS indicator's net-selling value (red) to increase and close at any value greater than zero, at this point you should exit the position.
Remember to always manage your risk, and don't invest more than you can afford to lose. Happy trading!
HALO: Bullish Pennant, not confirmed (+38%)Halo is showing yet again some positive pattern in price action.
Currently building into a bullish pennant (not confirmed) after last week's ascending triangle.
If the price action breaks the top of the flag with volume, we may be in for a 36-37% profit.
Target #1 on confirmed flag = 79.83$
Target #2 on confirmed ascending triangle = 87.93$ (See link)
Stay humble, Have fun, Make money!
HALO 2Mtest
Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development and commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. The firm products include rHuPH20, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.
HALO: Ascending Triangle WEEKLY (+70%)Hello all,
Haven't posted anything bullish in quite a while but I believe this one is worth a look.
Thank you to @TORNADOF5 for suggesting it.
HALO seem to have been untouched by the pandemic downtrend, as have many pharmaceutical companies.
So looking at the weekly chart, the price action has built into an ascending triangle that seems to have broken through the 51.50$ resistance with some volume. We may see some resistance around 56$ but none above that price range.
Target price = 87.93$ (+70%)
Stay humble, have fun, make money.
Relative Strength in Biotech - HALO(4/5) To highlight my point in the previous $VIVO post, here are 5 other charts in the Biotech sector that have shown relative strength lately. Don't get me wrong, the market is still on a downtrend, but should we reverse and start a new uptrend, this sector may potentially be the next one to lead a new bull market.